Rush Research: Tradition to Tomorrow
Like its highly regarded academic and clinical standards, Rush’s long-standing reputation in research also attracts some of the most innovative minds in medicine.
It was scientists at Rush who first determined the causes of scarlet fever and heart attacks, discovered sickle cell anemia, and developed one of the world’s first implantable pacemakers.
Today, Rush remains at the forefront of diseases from Alzheimer’s to osteoarthritis to AIDS, and is involved in more than 1,600 research studies, including trials of new medical and surgical therapies. Rush is a research leader in neurosciences, immunology, inflammation, infection, cancer and regenerative medicine.
Rush is also leading research in IT, as a member of the Chicago Area Patient-Centered Outcomes Research Network (CAPriCORN)—a data transfer infrastructure that supports the sharing and analysis of information on more than 1 million Chicago-area patients, potentially restructuring the nation’s patient research landscape.
These are reasons why Rush traditionally sees regular increases in NIH research funding. It is also why you can expect to be challenged, rewarded and recognized here throughout your career.
Senior researchers at Rush are often published in renowned peer review publications. Many participate in scientific and medical academic symposia, meetings and lectures at the national and international level, and present at professional meetings, courses and seminars. Many are members of national or international scientific review boards.
Tomorrow holds that same promise for you. Look into the national-level research that drives Rush University Medical Center. Explore opportunities to conduct research in medicine the way it should be.